Search results
Author(s):
Marko Kumric
,
Tina Ticinovic Kurir
,
Josko Bozic
,
et al
Added:
2 years ago
Author(s):
Hans-Peter Brunner-La Rocca
,
Sema Bektas
Added:
3 years ago
Although the first study on biomarker-guided therapy of chronic heart failure (HF) was published 15 years ago,1 there is still no real proof of the superiority of this approach as compared with standard therapy. The guidelines of the European Society of Cardiology simply state that: “several RCTs that evaluated natriuretic peptide-guided treatment (intensifying treatment in order to lower peptide…
View more
GDMT for Heart Failure
Author(s):
Edgar Francisco Carrizales-Sepúlveda
,
Alejandro Ordaz-Farías
,
José Arturo Vargas-Mendoza
,
et al
Added:
3 weeks ago
Article
CRT 2024
Start date:
Mar 09, 2024
End date:
Mar 12, 2024
Event
Author(s):
Giuseppe Rosano
,
Ilaria Spoletini
,
Cristiana Vitale
,
et al
Added:
3 years ago
Heart failure (HF) affects 1–2% of the population in developed countries and absorbs a significant amount of human and economic resources.1,2 HF is a complex syndrome characterised by a spectrum of symptoms and phenotypes: HF with preserved ejection fraction, HF with mid-range ejection fraction and HF with reduced ejection fraction (HFrEF).3 Differentiating patients according to left ventricular…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most impactful hot-line and late-breaking trials from ESC 2022.
Which trials should we look out for?
Trials covered in detail include:
TAILOR-PCI: Tailored Antiplatelet Therapy Following PCI
ASCEND: A Study of…
View more
Author(s):
Maurizio Volterrani
,
Ferdinando Iellamo
Added:
3 years ago
The US Public Health Service defines cardiac rehabilitation services as “comprehensive, long term programs involving medical evaluation, prescribed exercise, cardiac risk factor modification, education and counselling. These programs are designed to limit the physiological and psychological effect of cardiac illness, reduce the risk of sudden death or re-infarction, control cardiac symptoms,…
View more
Author(s):
Attilio Iacovoni
,
Emilia D’Elia
,
Mauro Gori
,
et al
Added:
3 years ago
Heart failure (HF) is a pandemic, chronic degenerative disease estimated to affect 38 million people worldwide, a number expected to increase with the ageing of the population.1 As a syndrome, it is associated with high mortality and morbidity, and consistently requires increasing resources. HF is the most frequent cause of hospitalisation in patients aged over 65 years, and hospitalised patients…
View more
Author(s):
David R Thompson
,
Chantal F Ski
,
Alexander M Clark
,
et al
Added:
1 year ago
Author(s):
Sebastian Rosch
,
Karl-Philipp Rommel
,
Markus Scholz
,
et al
Added:
3 years ago
Heart failure with preserved ejection fraction (HFpEF) is a common disease with rapidly increasing incidence and prevalence due to demographic changes.1 Well-known risk factors, such as metabolic syndrome (arterial hypertension, diabetes, obesity and dyslipidaemia), chronic kidney disease and AF, predispose to the development of HFpEF, especially in older people.
Establishing the clinical…
View more